Spastic type of cerebral palsy is the commonest disorder is associated with childhood disability. For spasticity corrections, orthopedic procedures are performed which are extremely painful. So, adequate pain relief is the priority during the immediate postoperative period for good perioperative outcomes. Ketamine being an N-Methyl D aspartate (NMDA) receptor antagonist blunts central pain sensation at a subanesthetic dose (0.3mg/kg or less IV) and is used as an adjuvant for perioperative analgesia. A subanesthetic dose has a minimal physiological impact as compared to an anesthetic dose. Ketamine, as a subanesthetic dose improves pain score and decreases opioid consumption during the perioperative period. We present, a case of a twelve-year-old female child known case of cerebral palsy came for spasticity correction of lower limbs under general anesthesia.
Keywords: Spastic diplegia, N-Methyl D aspartate (NMDA), perioperative analgesia